Article thumbnail

Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model

By Samuel García, Jerónimo Forteza, Carlos López-Otin, Juan J Gómez-Reino, Antonio González and Carmen Conde
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3046537
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). A: Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol
  2. (2008). A: Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol
  3. (2002). AAM: Increased mortality and inflammation in tumor necrosis factorstimulated gene-14 transgenic mice after ischemia and reperfusion injury.
  4. (2002). AE: Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acid Res
  5. (2003). AE: Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets
  6. (2006). Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum
  7. (2004). Bv8 and endocrine glandderived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA
  8. (2005). Cataldo DD: Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation.
  9. (2007). CM: LPS responsiveness and neutrophil chemotaxis in vivo require
  10. (2002). Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.
  11. (2008). Cytokine properties of prokineticins.
  12. (2003). Database for Annotation, Visualization, and Integrated Discovery. Genome Biol
  13. (1999). den Berg W: Cleavage of aggrecan at the Asn 341-Phe 342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum
  14. Expression Omnibus series accession number.
  15. (2004). Firestein GS: Rheumatoid arthritis: regulation of synovial inflammation.
  16. (2001). Gravallese EM: TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
  17. (2003). Hanemaaijer R: Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis
  18. (2002). Huizinga TW: Invasive properties of fibroblastlike synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis
  19. (2003). Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling.
  20. (2000). Iwakura Y: Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.
  21. (2008). Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol
  22. (1996). Kuettner KE: Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase.
  23. (2003). López-Otín C: Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet
  24. (2010). Mantovani A: Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol
  25. (2001). Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis
  26. (2000). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid artrhritis or osteoarthritis. Ann Rheum Dis
  27. (2008). McInnes IB: Evidence that cytokines plays a role in rheumatoid arthritis.
  28. (2003). Opdenakker G: Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun
  29. (1996). Organ-specific disease provoked by systemic autoimmunity. Cell
  30. (2006). Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther
  31. (2007). Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther
  32. (2005). Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis.
  33. (2004). S: Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
  34. (2007). Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol
  35. Schett G: TNF-induced structural joint damage is mediated by IL-
  36. (2003). Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology
  37. (2009). Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc
  38. (1997). T: Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factoralpha and doxycycline.
  39. (2005). Teitelbaum SL: IL-1 mediated TNFinduced osteoclastogenesis.
  40. (2002). The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibodyinduced arthritis.
  41. (1998). Visco DM: Susceptibility of stromelysin-1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum